Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ballou

Showing results (181-190 of 215) with videos related to

Pageof 22
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2023
<i>Cryptococcus neoformans</i> rapidly invades the murine brain by sequential breaching of airway and endothelial tissues barriers, followed by engulfment by microgliaVanessa I Francis, Corin Liddle, Emma Camacho, et al.
Nature Communications|November 8, 2023
Microglia are not protective against cryptococcal meningitisSally H Mohamed, Man Shun Fu, Sofia Hain, et al.
American Journal of Physiology. Renal Physiology|March 3, 2005
Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infectionsWenkai Dou, Sandra Thompson-Jaeger, Stanley J F Laulederkind, et al.
Infection and Immunity|May 1, 1996
Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malariaD E Lanar, J A Tine, C de Taisne, et al.
Infection and Immunity|October 24, 2007
Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primatesS Pichyangkul, U Kum-Arb, K Yongvanitchit, et al.
The Journal of Infectious Diseases|February 15, 2001
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malariaK E Kester, D A McKinney, N Tornieporth, et al.
Mbio|March 21, 2024
<i>Cryptococcus neoforman</i>s rapidly invades the murine brain by sequential breaching of airway and endothelial tissues barriers, followed by engulfment by microgliaVanessa I Francis, Corin Liddle, Emma Camacho, et al.
The American Journal of Tropical Medicine and Hygiene|February 16, 2000
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The GambiaJ F Doherty, M Pinder, N Tornieporth, et al.
Acta Tropica|September 30, 1997
SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in ThailandS Migasena, D G Heppner, D E Kyle, et al.
Vaccine|October 16, 1999
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoidW A Keitel, K E Kester, R L Atmar, et al.
Pageof 22

Showing results (181-190 of 215) with videos related to

Sort By:
Pageof 22
Biorxiv : the Preprint Server for Biology|November 28, 2023
<i>Cryptococcus neoformans</i> rapidly invades the murine brain by sequential breaching of airway and endothelial tissues barriers, followed by engulfment by microgliaVanessa I Francis, Corin Liddle, Emma Camacho, et al.
Nature Communications|November 8, 2023
Microglia are not protective against cryptococcal meningitisSally H Mohamed, Man Shun Fu, Sofia Hain, et al.
American Journal of Physiology. Renal Physiology|March 3, 2005
Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infectionsWenkai Dou, Sandra Thompson-Jaeger, Stanley J F Laulederkind, et al.
Infection and Immunity|May 1, 1996
Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malariaD E Lanar, J A Tine, C de Taisne, et al.
Infection and Immunity|October 24, 2007
Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS,S/AS01B vaccine in rhesus primatesS Pichyangkul, U Kum-Arb, K Yongvanitchit, et al.
The Journal of Infectious Diseases|February 15, 2001
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malariaK E Kester, D A McKinney, N Tornieporth, et al.
Mbio|March 21, 2024
<i>Cryptococcus neoforman</i>s rapidly invades the murine brain by sequential breaching of airway and endothelial tissues barriers, followed by engulfment by microgliaVanessa I Francis, Corin Liddle, Emma Camacho, et al.
The American Journal of Tropical Medicine and Hygiene|February 16, 2000
A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The GambiaJ F Doherty, M Pinder, N Tornieporth, et al.
Acta Tropica|September 30, 1997
SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in ThailandS Migasena, D G Heppner, D E Kyle, et al.
Vaccine|October 16, 1999
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoidW A Keitel, K E Kester, R L Atmar, et al.
Pageof 22